AKT1 and melanoma: Importantly, by mapping the effects of salidroside on these pathways by cluster analysis, we identified critical target molecules (AKT, mTOR, and MITF) that were directly affected by the compound, which may serve as biomarkers for assessing salidroside against melanoma growth and potential drug development.